4Muller GA,Muller CA,Einsele H,et al.Cytomegalovirus infection: how to manage it in the immunocompromised transplant recipient. Nephrology Dialysis Transplantation . 1994
5Blok MJ,Lautenschlager I,Christiaans MHL,et al.Nucleic acid sequencebased amplification: a new technique for monitoring cytomegalovirus infection in transplant recipients. Transplantation . 1999
6Said T,Nampoory MRN,Pacsa AS,et al.Cytomegalovirus infection in kidney transplant recipiets: early diagnosis and monitoring of antiviral therapy by the antigenenia assay. Transplantation . 2001
7Judith E,Feinberg,Shelley Hurwitz,et al.A randomized, double-blind trial of Valaciclovir prophylaxis for cytomegalovirus disease in patients with advaced human immunodeficiency virus infection. The Journal of Infectious Diseases . 1998
8Louance D,Neumayer HH,Legendre C,et al.Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. The New England Journal of Medicine . 1999
9Gupta R,Gonczol E,Manning ML,et al.Delayed type hypersensitivity to human cytomegalovirus. Journal of Medical Virology . 1993
10Gyulai Z,Endresz U,Burian K,et al.Cytotoxic T lymphocyte(CTL) responses to human cytomegalovirus pp65, IE-1, gB, pp150, and pp28 in healthy individuals: reev-aluation of prevalence of IE1-specific CTLS. The Journal of Infectious Diseases . 2000
